IPPRA / Grant Monitor

2026-09-06
3129Open opportunities
2503Characterized
0Not yet characterized
580Awaiting detail
2026-09-05Last fetch
Lens
Deadline
Funds
Topic
Category
Funds Opportunity Topics Ceiling Posted Closes Days
evaluation research Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) RFA-DK-27-139 · National Institutes of Health biomedical clinical public health ai data science 2026-08-31 2026-11-09 64
evaluation research DoW Vision, Clinical Trial Award HT942526VRPCTA · Defense Health Agency Contracting Activity - DHACA biomedical clinical public health 2026-05-05 2026-11-12 67
evaluation research Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) PAR-25-274 · National Institutes of Health biomedical clinical public health mental behavioral health 2024-11-21 2026-11-17 72
evaluation research Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) PAR-25-268 · National Institutes of Health biomedical clinical public health mental behavioral health 2024-11-21 2026-11-17 72
evaluation research NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) PAR-25-267 · National Institutes of Health biomedical clinical mental behavioral health public health $350,000 2024-11-21 2026-11-17 72
evaluation research DoW Breast Cancer, Clinical Research Extension Award HT942526BCRPCREA2 · Defense Health Agency Contracting Activity - DHACA biomedical clinical public health 2026-09-03 2026-11-18 73
evaluation research NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) PAR-25-025 · National Institutes of Health biomedical clinical public health ai data science $1,515,000 2024-12-05 2027-01-07 123
evaluation research NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) PAR-25-026 · National Institutes of Health biomedical clinical public health 2024-12-05 2027-01-07 123

8 OF 8 ROWS